RegeneRx Biopharmaceuticals, Inc. Share Price Other OTC
Equities
RGRX
US75886X1081
Pharmaceuticals
Sales 2021 | 76.76K 6.14M | Sales 2022 | 76.76K 6.14M | Capitalization | 19.94M 1.6B |
---|---|---|---|---|---|
Net income 2021 | -1M -80.03M | Net income 2022 | -1M -80.03M | EV / Sales 2021 | 298 x |
Net cash position 2021 | 66.69K 5.34M | Net Debt 2022 | 1.16M 92.47M | EV / Sales 2022 | 275 x |
P/E ratio 2021 |
-13.9
x | P/E ratio 2022 |
-11.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 55.86% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 86 | 12/05/82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 31/12/83 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 31/12/83 |
Founder | 86 | 12/05/82 | |
Joe McNay
BRD | Director/Board Member | 90 | 31/12/01 |
1st Jan change | Capi. | |
---|---|---|
-4.24% | 86.85B | |
+2.76% | 40.16B | |
-16.98% | 31.28B | |
+57.86% | 25.27B | |
-16.24% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
-17.10% | 11.69B | |
+6.89% | 8.83B |